Centre National De La Recherche Scientifique

Vect-horus

Université´ D'aix-marseille

Pascaline Lecorche

Michel Khrestchatisky

Jamal Temsamani

Marion David

Yves Molino

Guillaume Jacquot

Jonathan Nowak

Cédric Malicet

Jd Malcor

Nadine Payrot

The present invention relates to a conjugated compound comprising a marker M pharmaceutically acceptable, and a peptide or pseudo-peptide P having at most 30 amino acid residues and able to bind the Low-Density Lipoprotein Receptor (LDLR) and to its use in a method of labelling and/or detecting and/or treating cancerous cells in a subject by administration of the conjugated compound to the subject an analysis of the presence and/or the amount of marker.

Compositions and methods for cancer imaging and radiotherapy

The present invention relates to activated neurotensin, pharmaceutical compositions comprising the same, and the uses thereof. The compounds and compositions of the invention may be used, e.g., to reduce body temperature, attenuate or halt seizures, reduce excitotoxicity, promote neuroprotection, reduce neuroinflammation and aberrant axonal sprouting or reduce pain.

Activated neurotensin molecules and the uses thereof

Growing community of inventors

Marseilles, France

Pascaline Lecorche